Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
31787 University of Rochester Adult HIV Therapeutic Strategies Network CRS
354
mi
from 43215
Rochester, NY
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
31787 University of Rochester Adult HIV Therapeutic Strategies Network CRS
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Unc Aids Crs
353
mi
from 43215
Chapel Hill, NC
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Unc Aids Crs
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Univ. of Cincinnati CRS (2401)
98
mi
from 43215
Cincinnati, OH
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Univ. of Cincinnati CRS (2401)
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Case CRS (2501)
127
mi
from 43215
Cleveland, OH
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Case CRS (2501)
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Hosp. of the Univ. of Pennsylvania CRS (6201)
416
mi
from 43215
Philadelphia, PA
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Hosp. of the Univ. of Pennsylvania CRS (6201)
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Houston AIDS Research Team CRS (31473)
991
mi
from 43215
Houston, TX
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Houston AIDS Research Team CRS (31473)
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
University of Washington AIDS CRS (1401)
2006
mi
from 43215
Seattle, WA
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
University of Washington AIDS CRS (1401)
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Washington University CRS (2101)
394
mi
from 43215
Saint Louis, MO
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Washington University CRS (2101)
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
Whitman Walker Health CRS (31791)
327
mi
from 43215
Washington,
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
Whitman Walker Health CRS (31791)
327
mi
from 43215
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated:  12/31/1969
University of Miami AIDS CRS (901)
996
mi
from 43215
Miami, FL
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive ART
Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy
Status: Enrolling
Updated: 12/31/1969
University of Miami AIDS CRS (901)
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Center CRS
1979
mi
from 43215
Los Angeles, CA
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Center CRS
1979
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
UCSD Antiviral Research Center CRS
1951
mi
from 43215
San Diego, CA
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
UCSD Antiviral Research Center CRS
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA CRS
1980
mi
from 43215
Torrance, CA
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA CRS
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Northwestern University CRS
274
mi
from 43215
Chicago, IL
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Northwestern University CRS
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University CRS
345
mi
from 43215
Baltimore, MD
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University CRS
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
New Jersey Medical School Clinical Research Center CRS
467
mi
from 43215
Newark, NJ
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
New Jersey Medical School Clinical Research Center CRS
467
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Chelsea CRS
477
mi
from 43215
New York, NY
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Chelsea CRS
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Uptown CRS
479
mi
from 43215
New York, NY
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Uptown CRS
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
University of Rochester Adult HIV Therapeutic Strategies Network CRS
354
mi
from 43215
Rochester, NY
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
University of Rochester Adult HIV Therapeutic Strategies Network CRS
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Chapel Hill CRS
350
mi
from 43215
Chapel Hill, NC
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Chapel Hill CRS
350
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Greensboro CRS
322
mi
from 43215
Greensboro, NC
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Greensboro CRS
322
mi
from 43215
Greensboro, NC
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Case Clinical Research Site
129
mi
from 43215
Cleveland, OH
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Case Clinical Research Site
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Ohio State University CRS
2
mi
from 43215
Columbus, OH
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Ohio State University CRS
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Penn Therapeutics Crs
414
mi
from 43215
Philadelphia, PA
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Penn Therapeutics Crs
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh CRS
165
mi
from 43215
Pittsburgh, PA
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh CRS
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Vanderbilt Therapeutics (VT) CRS
335
mi
from 43215
Nashville, TN
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Vanderbilt Therapeutics (VT) CRS
335
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Trinity Health and Wellness Center CRS
911
mi
from 43215
Dallas, TX
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Trinity Health and Wellness Center CRS
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Houston AIDS Research Team CRS
995
mi
from 43215
Houston, TX
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Houston AIDS Research Team CRS
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
University of Washington AIDS CRS
2006
mi
from 43215
Seattle, WA
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
University of Washington AIDS CRS
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Cincinnati Clinical Research Site
98
mi
from 43215
Cincinnati, OH
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Cincinnati Clinical Research Site
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
The Miriam Hospital Clinical Research Site (TMH CRS) CRS
620
mi
from 43215
Providence, RI
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
The Miriam Hospital Clinical Research Site (TMH CRS) CRS
620
mi
from 43215
Providence, RI
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Washington University Therapeutics (WT) CRS
394
mi
from 43215
Saint Louis, MO
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Washington University Therapeutics (WT) CRS
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Whitman-Walker Health CRS
327
mi
from 43215
Washington,
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Whitman-Walker Health CRS
327
mi
from 43215
Washington,
Click here to add this to my saved trials
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated:  12/31/1969
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS
5039
mi
from 43215
Rio de Janeiro,
Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)
A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification With Maraviroc and Dolutegravir With No Intensification or Intensification With Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV
Status: Enrolling
Updated: 12/31/1969
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS
5039
mi
from 43215
Rio de Janeiro,
Click here to add this to my saved trials
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort
Collaborative Care Intervention to Improve Providers' Opioid Prescribing for HIV-infected Patients - Patient Cohort Component
Status: Enrolling
Updated:  12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort
Collaborative Care Intervention to Improve Providers' Opioid Prescribing for HIV-infected Patients - Patient Cohort Component
Status: Enrolling
Updated: 12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort
Collaborative Care Intervention to Improve Providers' Opioid Prescribing for HIV-infected Patients - Patient Cohort Component
Status: Enrolling
Updated:  12/31/1969
Boston Med Ctr
642
mi
from 43215
Boston, MA
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort
Collaborative Care Intervention to Improve Providers' Opioid Prescribing for HIV-infected Patients - Patient Cohort Component
Status: Enrolling
Updated: 12/31/1969
Boston Med Ctr
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Anakinra, a Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Anakinra, a Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Anakinra, a Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Anakinra, a Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
Georgetown University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Medical Center
345
mi
from 43215
Baltimore, MD
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Medical Center
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
322
mi
from 43215
Bethesda, MD
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
Mt. Sinai Medical Center
480
mi
from 43215
New York, NY
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
Mt. Sinai Medical Center
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
Columbia University
481
mi
from 43215
New York, NY
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
Columbia University
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
A Retrospective/Prospective Cohort Study to Assess Safety, Tolerability, and Efficacy of Sofosbuvir Based Direct Acting Antiviral (DAA) Therapy for Hepatitis C Treatment in HIV/HCV Coinfected Subjects Pre or Post Liver Transplant
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1979
mi
from 43215
Beverly Hills, CA
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
An Evaluation of Bone Mineral Density in HIV-1-infected Adult Subjects Switching From a Tenofovir-containing Antiretroviral Therapy Regimen to a Dolutegravir Plus Rilpivirine Regimen
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials